The Chemistry and Pharmaceutical sciences group at Vrije Universiteit Amsterdam (VU) has recently rejoined Innovation Lab Chemistry (ILCA), which provides innovation support to chemical companies, supported by various organisations in the region. With this participation, the VU hopes to contribute new knowledge and expertise in addition to the existing universities that are already part of the Innovation Lab.
At ILCA it is seen as good news: “We are very pleased that VU adds their Pharmaceutical chemistry knowledge to the portfolio of expertise of ILCA. This means that companies and organizations in the MRA can benefit from a broader range of services to support their innovations and operational challenges”, says Willem Fokkema, director at ILCA.
The participation of VU will be coordinated by IXA-VU. “We make sure that questions from companies arrive on the right place” adds Ties van Rappard, business developer at VU. “We have extensive pharmaceutical expertise and (analytical) infrastructure in the labs of Prof Tom Grossmann useful for Lifesciences startup companies but also for mature companies in need for specific instruments. Regardless the question; analysis or synthesis. We find solutions”.
PULSE Sport, a start-up from the Demonstrator Lab, has reached a significant milestone by winning the prestigious 14th Dutch Sports Innovation Award. The company’s flagship product, a cutting-edge athlete management system, integrates advanced software and artificial intelligence to revolutionize athlete health and performance monitoring. About the Innovation PULSE Sport’s athlete management system provides a holistic […]
NewsVU-AMS is on a mission to revolutionize how we understand and manage stress-related health issues. Now an official VU spin-off, there are big plans for clinical applications. Founder of VU AMS Martin Gevonden explains: “We offer researchers autonomic biomarkers that are valid, reliable and easy to use, without getting under the skin.” After thriving in […]
NewsAmsterdam researchers have secured Biotech Booster funding for a total of six projects, that include a promising cancer treatment, a new diagnostic method for Alzheimer’s Disease, an implant helping blindness, lab innovation in biotechnology, and a nutritional intervention for mental health. The researchers will develop a solid business case for their innovations in the time […]
News